Navigation Links
TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Date:8/19/2007

om migraines. In addition to headache pain, migraine attacks are frequently accompanied by photophobia, phonophobia, nausea, and vomiting. Although once thought to be primarily caused by vascular changes in the brain, some researchers now consider migraine a neurological disorder.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a clinical stage biopharmaceutical company that discovers and develops small molecule drugs to treat diseases and disorders of the central nervous system (CNS). Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, including Alzheimer's disease and cognitive impairment associated with schizophrenia. Further information is available at http://www.torreypinestherapeutics.com.

This press release contains forward-looking statements or predictions. Such forward-looking statements include statements regarding the potential for tezampanel as a treatment for migraine and other pain indications and the potential of the company's product candidates to treat certain diseases and disorders. Such statements are subject to numerous factors, risks, and uncertainties that may cause actual events or results to differ materially from the combined company's current expectations. Statements regarding TorreyPines Therapeutics' product candidates are subject to risks and uncertainties regarding development, regulatory approval and commercialization, including whether any preclinical studies or clinical trials, either ongoing or conducted in the future, will prove successful, and if successful, whether the results can be replicated; whether safety and efficacy profiles of any of its drug candidates will be established, or if established, will remain the same, be better or worse in future clinica
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... MENLO PARK, Calif. , July 6, 2015 /PRNewswire/ ... of its 2015 Internal Auditing around the World ... decade, Protiviti has analyzed and reported on the evolution ... select companies from around the globe as a means ... a deeper understanding of this strategic business function. ...
(Date:7/6/2015)... 6, 2015 Hologic, Inc. (NASDAQ: HOLX ... its financial results for the third quarter of fiscal ... closes.  In conjunction with the release, management will host ... Time. Interested participants may listen to the ... States ) or 719-325-4804 (for international callers) and ...
(Date:7/6/2015)... 6, 2015 E-QURE Corp (OTCQB: EQUR), today ... at VirtualInvestorConferences.com on July 9, 2015. DATE: Thursday, ... This will be a live, ... the company questions in real-time - both in the ... booth." If attendees are not able to join the ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... PharmacoFore, Inc., a privately held biopharmaceutical company ... results from a Phase I human proof-of-concept (hPOC) ... (Bio-MD™) product candidate, PF329.  Greg Sturmer, VP, Finance ... Business Forum during the annual BIO International Convention ...
... AUSTIN, Texas, June 23, 2011 Luminex Corporation (NASDAQ: ... Awards - Stevie Awards - Most Innovative Company of ... and Business Innovation of the Year for the MAGPIX ... year with more than 2,800 organizations from virtually all ...
Cached Medicine Technology:PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 2PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 3PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was 4Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System 2Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System 3
(Date:7/6/2015)... ... July 06, 2015 , ... In order to recognize ... Orthopaedic Society for Sports Medicine ( AOSSM ) will present ten research awards ... As a leader in orthopaedic sports medicine, AOSSM annually provides more than $350,000 ...
(Date:7/6/2015)... ... July 06, 2015 , ... Hundreds of thousands of ... which is why liposuction regularly ranks among the top five most popular cosmetic ... become more than a way to slim down a silhouette for swimsuit season. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, ... has partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ... medical conditions. Screenings are affordable and accurate and run about an hour long ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing urgent ... constructed urgent care center will serve residents and visitors in the Cutler Bay area, ... Now’s 22nd South Florida location, the new facility will be the fourth to serve ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering the ... Kybella is a non-surgical method to dissolve fat cells and is the first ... fat deposits under the chin, commonly known as a double chin. Dr. Green participated ...
Breaking Medicine News(10 mins):Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... how they help arteries stay clear and healthy , TUESDAY, ... researchers have begun to discover the exact molecular reasons why ... and ordinary orange juice are good for the health of ... studies describing the range of genes that are affected by ...
... , , OWINGS MILLS, Md., ... leading portion-controlled weight-loss program, today announced the launch of Honey Mustard ... and Parmesan Cheese Puffs. The new pretzel sticks and cheese puffs ... & 1 Plan, while also maintaining the nutritional value of Medifast ...
... to Treat Diseases (HTDS.PK) www.htdsmedical.com announced today ... the country of Thailand. The registration is expected to ... This registration is required to accommodate a customer from ... products such as MEVAC-A, MEVAC-DTaP, and MEVAC-ACYW. , Mellow ...
... N.H., July 21 Emerson Ecologics, LLC today announced that ... Michelle will develop and implement new business opportunities while maintaining ... , , "Michelle brings a ... this important new position," said Fran Towey, CEO of Emerson ...
... (July 21, 2009) Columbia University Medical Center,s Jeffrey ... of schizophrenia, has been selected by the National Institute ... Health as principal investigator of a nationwide effort to ... experiencing a first episode of the psychotic symptoms of ...
... Chinese patients will soon have the opportunity to take ... at reversing the autoimmune disease, ankylosing spondylitis. Approximately 200 ... trial that aims to merge the latest molecular discoveries ... with the medical expertise of physicians and researchers at ...
Cached Medicine News:Health News:Studies Show Genetic Activity of Antioxidants 2Health News:Studies Show Genetic Activity of Antioxidants 3Health News:Medifast Adds Pretzel and Puffs to Meal Replacement Line 2Health News:Medifast Adds Pretzel and Puffs to Meal Replacement Line 3Health News:Hard To Treat Diseases (HTDS.PK) Thailand Registration 2Health News:Emerson Ecologics Names Michelle Hebert New England Regional Sales Representative 2Health News:Columbia leads national effort to develop early intervention for schizophrenia 2Health News:Columbia leads national effort to develop early intervention for schizophrenia 3Health News:Study aims to induce recovery from ankylosing spondylitis 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: